Interactive Session:
77. "Mano-a-Mano IV": Controversies in Pediatric ID
Thursday, October 4, 2018: 2:00 PM-3:15 PM
Room: S 206-208

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • explain the differences between tuberculin skin test vs. IGRA in the initial evaluation of children for TB
  • discuss the benefits of vancomycin for empiric therapy for meningitis
  • describe associated benefits of respiratory viral panel testing

Target Audience: Academicians, Clinicians, Epidemiologists, Fellows, Healthcare workers, Infectious diseases pediatricians, Infectious diseases physicians, Medical students and residents, Pharmacists

Tracks: Trainee, Pediatric ID, Epidemiology and Infection Control

Interactive Moderators:  Natasha Halasa, MD, MPH, Vanderbilt University Medical Center and Ravi Jhaveri, MD, FIDSA, FPIDS, University of North Carolina School of Medicine

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE

ACPE Number: 0221-9999-18-308-L01-P


N. Halasa, Sanofi Pasteur: Investigator , Research support . GSK: Consultant , Consulting fee . Moderna: Consultant , Consulting fee .

R. Jhaveri, Abbvie: Investigator , Research support . Gilead: Investigator , Research support . Merck: Grant Investigator , Grant recipient .

See more of: Interactive Session

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.